Clotrimazole (Candaspor Vaginal, Candaspor)
Clotrimazole
Ranbaxy Pharmaceutical (Pty) Ltd
Registration
- Applicant
- Ranbaxy Pharmaceutical (Pty) Ltd
- Certificate holder
- Ranbaxy Pharmaceuticals (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Candaspor vaginal cream EACH 1 g CREAM CONTAINS CLOTRIMAZOLE 10 mg | 10 mg/1gCream | Y0289Y/20.2.2/289Approved 13 January 2022 | Registered | Not determined | PIPIL |
| Candaspor cream* EACH 1 g CREAM CONTAINS CLOTRIMAZOLE 10 mg | 10 mg/1gCream | Y0290Y/20.2.2/290Approved 31 August 2021 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Clotrimazole
- except when intended for application to the skin (S1) and when intended for human vaginal use, specifically for the treatment of recurrent vaginal candidiasis. (S1)
Consolidated Schedules 06 July 2026, lines 5859 to 5860
S1: Clotrimazole
- when intended for human vaginal use specifically for the treatment of recurrent vaginal candidiasis; (S4) and
- when intended for application to the skin. (S4)
Consolidated Schedules 06 July 2026, lines 330 to 335
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1-[(2-Chlorophenyl)-diphenylmethyl]imidazole
Drag to rotate. Structure from PubChem CID 2812.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.